StonvexLoading…
StonvexStonvexStonvexCore line items from ORN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $216.30M | $852.26M | $619.04M | $393.94M |
Operating Income | $-795.00K | $14.61M | $9.59M | $4.26M |
Net Income | $4.69M | $2.49M | $2.73M | $841.00K |
EPS (Diluted) | $0.12 | $0.06 | $0.07 | $-0.01 |
Total Assets | $478.72M | $414.65M | $422.38M | $432.72M |
Total Liabilities | $312.06M | $255.62M | $264.49M | $279.53M |
Cash & Equivalents | $6.25M | $1.59M | $4.92M | $1.73M |
Free Cash Flow OCF − CapEx | $-3.65M | $-10.80M | $-11.25M | $-25.17M |
Shares Outstanding | 40.48M | 39.90M | 39.89M | 39.74M |